Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: UBS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on UBS, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 24,604 UBS shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 24,604 shares
    Change vs previous 13F -562,450 shares

    0.02% of the 13F portfolio, value $1,221,889.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 587,054 shares
    Change vs previous 13F -303,378 shares

    0.43% of the 13F portfolio, value $22,450,603.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 890,432 shares
    Change vs previous 13F -199,422 shares

    0.87% of the 13F portfolio, value $41,543,489.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 1,089,854 shares
    Change vs previous 13F -1,342,375 shares

    1% of the 13F portfolio, value $44,534,442.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 2,432,229 shares
    Change vs previous 13F -252,060 shares

    2.54% of the 13F portfolio, value $82,048,092.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 2,684,289 shares
    Change vs previous 13F +234,528 shares

    2.55% of the 13F portfolio, value $81,528,825.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 2,449,761 shares
    Change vs previous 13F +585,319 shares

    2.61% of the 13F portfolio, value $74,965,319.

    13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 1,864,442 shares
    Change vs previous 13F not available

    2% of the 13F portfolio, value $57,602,803.

    13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).